High-mobility group box 1 is involved in the initial events of early loss of transplanted islets in mice

Journal of Clinical Investigation

Volumn 120, Issue 3, 2010, Pages 735-743

  Matsuoka, Nobuhide ^a   Itoh, Takeshi ^a   Watarai, Hiroshi ^b   Sekine Kondo, Etsuko ^b   Nagata, Naoki ^c   Okamoto, Kohji ^c   Mera, Toshiyuki ^a   Yamamoto, Hiroshi ^d   Yamada, Shingo ^e   Maruyama, Ikuro ^f   Taniguchi, Masaru ^b   Yasunami, Yohichi ^a  

^a FUKUOKA UNIVERSITY   (Japan)

^b RIKEN Center for Integrative Medical Sciences   (Japan)

^c UNIVERSITY OF OCCUPATIONAL AND ENVIRONMENTAL HEALTH   (Japan)

^d KANAZAWA UNIVERSITY GRADUATE SCHOOL OF MEDICAL SCIENCE   (Japan)

^e SHINO TEST CORPORATION   (Japan)

^f KAGOSHIMA UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CD11B ANTIGEN; CD40 LIGAND MONOCLONAL ANTIBODY; GAMMA INTERFERON; HIGH MOBILITY GROUP B1 PROTEIN ANTIBODY; IMMUNOSUPPRESSIVE AGENT; INTERLEUKIN 12; RECEPTOR FOR ADVANCED GLYCATION END PRODUCT; TOLL LIKE RECEPTOR 2; TOLL LIKE RECEPTOR 4; TRANSCRIPTION FACTOR; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL ACTIVATION; CELL STIMULATION; CIRCULATION; CONTROLLED STUDY; CYTOKINE PRODUCTION; DENDRITIC CELL; DIABETES MELLITUS; DRUG MECHANISM; ENZYME INHIBITION; GRAFT FAILURE; IN VITRO STUDY; IN VIVO STUDY; LIVER; MONONUCLEAR CELL; MOUSE; NATURAL KILLER T CELL; NONHUMAN; PANCREAS ISLET TRANSPLANTATION; PRIORITY JOURNAL; PROTEIN EXPRESSION; UPREGULATION;

ANIMALS; ANTIBODIES; ANTIGENS, CD11B; ANTIGENS, CD40; CD40 LIGAND; DENDRITIC CELLS; DIABETES MELLITUS, EXPERIMENTAL; DIABETES MELLITUS, TYPE 1; GRAFT REJECTION; HMGB1 PROTEIN; INTERFERON-GAMMA; INTERLEUKIN-12; ISLETS OF LANGERHANS; ISLETS OF LANGERHANS TRANSPLANTATION; LIVER; MICE; MICE, KNOCKOUT; MITOGEN-ACTIVATED PROTEIN KINASES; NATURAL KILLER T-CELLS; TOLL-LIKE RECEPTOR 2; TOLL-LIKE RECEPTOR 4;

EID: 77949756774     PISSN: 00219738     EISSN: 15588238     Source Type: Journal    
DOI: 10.1172/JCI41360     Document Type: Article

References (40)

1. Shapiro AM, et al. Islet transplantation in seven patients with type 1 diabetes mellitus using a glucocorticoid-free immunosuppressive regimen. N Engl J Med. 2000;343(4):230-238.
2. + cells mediates early graft loss of syngeneic transplanted islets. J Exp Med. 2005;202(7):913-918.
3. Muller S, Ronfani L, Bianchi ME. Regulated expression and subcellular localization of HMGB1, a chromatin protein with a cytokine function. J Internal Med. 2004;255(3):332-343.
4. Seong SY, Matzinger P. Hydrophobicity: an ancient damage-associated molecular pattern that initiates innate immune responses. Nat Rev Immunol. 2004;4(6):469-478.
5. Lotze MT, Tracey KJ. High-mobility group box 1 protein (HMGB1): nuclear weapon in the immune arsenal. Nat Rev Immunol. 2005;5(4):331-342.
6. Wang H, et al. HMG-1 as a late mediator of endotoxin lethality in mice. Science. 1999;285(5425):248-251.
7. Gardella S, et al. The nuclear protein HMGB1 is secreted by monocytes via a non-classical, vesicle-mediated secretory pathway. EMBO Rep. 2002;3(10):995-1001.
8. Dumitriu IE, et al. Release of high mobility group box 1 by dendritic cells controls T cell activation via the receptor for advanced glycation end products. J Immunol. 2005;174(12):7506-7515.
9. Semino C, Angelini G, Poggi A, Rubartelli A. NK/iDC interaction results in IL-18 secretion by DCs at the synaptic cleft followed by NK cell activation and release of the DC maturation factor HMGB1. Blood. 2005;106(2):609-616.
10. Park JS, et al. Involvement of Toll-like receptors 2 and 4 in cellular activation by high mobility group box 1 protein. J Biol Chem. 2004;279(9):7370-7377.
11. Park JS, et al. High mobility group box 1 protein interacts with multiple Toll-like receptors. Am J Physiol Cell Physiol. 2006;290(3):C917-C924.
12. Scaffidi P, Misteli T, Bianchi ME. Release of chromatin protein HMGB1 by necrotic cells triggers inflammation. Nature. 2002;418(6894):191-195.
13. Hori O, et al. The receptor for advanced glycation endproducts (RAGE) is a cellular binding site for amphoterin: mediation of neurite out-growth and coexpression of RAGE and amphoterin in the developing nervous system. J Biol Chem. 1995;270(43):25752-25761.
14. Kokkola R, et al. RAGE is the major receptor for the proinflammatory activity of HMGB1 in rodent macrophages. Scand J Immunol. 2005;61(1):1-9.
15. Sha Y, Zmijewski J, Xu Z, Abraham E. HMGB1 develops enhanced proinflammatory activity by binding to cytokines. J Immunol. 2008;180(4):2531-2537.
16. Tian J, et al. Toll-like receptor 9-dependent activation by DNA-containing immune complexes is mediated by HMGB1 and RAGE. Nat Immunol. 2007;8(5):487-496.
17. Urbonaviciute V, et al. Induction of inflammatory and immune responses by HMGB1-nucleosome complexes: implications for the pathogenesis of SLE. J Exp Med. 2008;205(13):3007-3018.
18. Mosevitsky MI, Novitskaya VA, Logannsen MG, Zebezhinsky MA. Tissue specificity of nucleo-cytoplasmic distribution of HMGl and HMG2 proteins and their probable functions. Eur J Biochem. 1989;185(2):303-310.
19. Saldeen J. Cytokines induce both necrosis and apoptosis via a common Bcl-2-inhibitable pathway in rat insulin-producing cells. Endocrinology. 2000;141(6):2003-2010.
20. Steer SA, Scarim AL, Chambers KT, Corbett JA. Interleukin-1 stimulates β cell necrosis and release of the immunological adjuvant HMGB1. PloS Med. 2006;3(2):e17. doi:10.1371/journal.pmed.0030017.
21. + NKT cells: stimulation of IL-12 production by antigen-presenting cells in the innate immune system. J Immunol. 1999;163(1):93-101.
22. Brigl M, Bry L, Kent SC, Gumperz JE, Brenner MB. Mechanism of CD1d-restricted natural killer T cell activation during microbial infection. Nat Immunol. 2003;4(12):1230-1237.
23. Satoh M, et al. Successful islet transplantation to two recipients from a single donor by targeting pro-inflammatory cytokines in mice. Transplantation. 2007;83(8):1085-1092.
24. Tsung A, et al. HMGB1 release induced by liver ischemia involves Toll-like receptor 4-dependent reactive oxygen species production and calcium-mediated signaling. J Exp Med. 2007;204(12):2913-2923.
25. Yanai H, et al. HMGB proteins function as universal sentinels for nucleic-acid-mediated innate immune responses. Nature. 2009;462(7269):99-103.
26. Chen Y, et al. RAGE ligation affects T cell activation and controls T cell differentiation. J Immunol. 2008;181(6):4272-4278.
27. Jiang X, et al. Cutting edge: critical role of CXCL16/CXCR6 in NKT cell trafficking in allograft tolerance. J Immunol. 2005;175(4):2051-2055.
28. Cui J, et al. Requirement for Vα14 NKT cells in IL-12-mediated rejection of tumors. Science. 1997;278(5343):1623-1626.
29. Myint KM, et al. Effects of RAGE gene disruption and administration of low-molecular weight heparin. Diabetes. 2006;55(9):2510-2522.
30. Sutton R, Peters M, McShane P, Gray DW, Morris PJ. Isolation of rat pancreatic islets by ductal injection of collagenase. Transplantation. 1986;42(6):689-691.
31. Okeda T, Ono J, Takaki R, Todo S. Simple method for the collection of pancreatic islets by the use of Ficoll-Conray gradient. Endocrinol Jpn. 1979;26(4):495-499.
32. Kemp CB, Knight MJ, Scharp DW, Lacy PE, Ballinger WF. Transplantation of isolated pancreatic islets into the portal vein of diabetic rats. Nature. 1973;244(5410):447.
33. Shibao K, et al. Enhanced coexpression of YB-1 and DNA topoisomerase IIα genes in human colorectal carcinomas. Int J Cancer. 1999;83(6):732-737.
34. Yamada S, Yakabe K, Ishii J, Imaizumi H, Maruyama I. New high mobility group box 1 assay system. Clin Chim Acta. 2006;372(1-2):173-178.
35. Sanders O. A method for the fractionation of the high-mobility-group non-histon chromosomal proteins. Biochem Biophys Res Commun. 1977;78(3):1034-1042.
36. Ito T, et al. High-mobility group box 1 protein promotes development of microvascular thrombosis in rats. J Thromb Haemost. 2007;5(1):109-116.
37. Abeyama K, et al. The N-terminal domain of thrombomodulin sequesters high-mobility group-B1 protein, a novel antiinflammatory mechanism. J Clin Invest. 2005;115(5):1267-1274.
38. Ueno H, et al. Contributions of high mobility group box protein in experimental and clinical acute lung injury. Am J Respir Crit Care Med. 2004;170(12):1310-1316.
39. Watarai H, Nakagawa R, Omori-Miyake M, Dashtsoodol N, Taniguchi M. Methods for detection, isolation and culture of mouse and human invariant NKT cells. Nat Protoc. 2008;3(1):70-78.
40. + in the liver in association with intrahepatic islet xenograft rejection from rat to mouse: prevention of rejection with anti-IL-2Rβ monoclonal antibody treatment. Transplantation. 1997;64(4):633-639.